| [1] |
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 [J]. Int J Cancer, 2015, 136(5): E359-386.
|
| [2] |
Ernster VL, Barclay J. Increase in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma [J]. Natl Cancer Monogr, 1997, (22): 151-156.
|
| [3] |
Allred DC, Wu Y, Mao S, et al. Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution [J]. Clin Cancer Res, 2008, 14(2): 370-378.
|
| [4] |
Leong AS, Sormumen RT, Vinyuvat S, et al. Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma. A comparison of eight contemporary grading systems [J]. Am J Clin Pathol, 2001, 115(5): 709-718.
|
| [5] |
邵志敏，沈镇宙，徐兵河. 乳腺肿瘤学[M]. 上海：复旦大学出版社，2013.
|
| [6] |
Moreno A, Lloveras B, Figueras A, et al. Ductal carcinoma in situ of the breast: correlation between histologic classifications and biologic markers[J]. Mod Pathol, 1997, 10(11): 1088-1092.
|
| [7] |
Erbas B, Provenzano E, Armes J, et al. The natural history of ductal carcinoma in situ of the breast: a review[J]. Breast Cancer Res Treat, 2006, 97(2): 135-144.
|
| [8] |
Gradishar WJ, Anderson BO, Balassanian R, et al. NCCN clinical practice guidelines in oncology: breast cancer version 2. 2016[EB/OL]. [2017-03-10].
URL
|
| [9] |
Fowble B, Hanlon AL, Fein DA, et al. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS) [J]. Int J Radiat Oncol Biol Phys, 1997, 38(5): 949-957.
|
| [10] |
Kestin LL, Goldstein NS, Martinez AA, et al. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10-year results [J]. Ann Surg, 2000, 231(2): 235-245.
|
| [11] |
Fisher B, Land S, Mamounas E, et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience[J]. Semin Oncol, 2001, 28(4): 400-418.
|
| [12] |
EORTC Breast Cancer Cooperative Group, EORTC Radiotherapy Group, Bijker N, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase Ⅲ trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group [J]. J Clin Oncol, 2006, 24(21): 3381-3387.
|
| [13] |
Houghton J, George WD, Cuzick J, et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial [J]. Lancet, 2003, 362(9378): 95-102.
|
| [14] |
Cuzick J, Sestak I, Pinder SE, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial[J]. Lancet Oncol, 2011, 12(1): 21-29.
|
| [15] |
Emdin SO, Granstrand B, Ringberg A, et al. SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening [J]. Acta Oncol, 2006, 45(5): 536-543.
|
| [16] |
Wärnberg F, Garmo H, Emdin S, et al. Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial [J]. J Clin Oncol, 2014, 32(32): 3613-3618.
|
| [17] |
Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS[J]. J Natl Cancer Inst, 2011, 103(6): 478-488.
|
| [18] |
Recht A. Are the randomized trials of radiation therapy for ductal carcinoma in situ still relevant [J]．J Clin Oncol, 2014, 32(32): 3588-3590.
|
| [19] |
Wong FY, Wang F2, Chen JJ, et al. Outcomes of low-risk ductal carcinoma in situ in Southeast Asian women treated with breast conservation therapy [J]. Int J Radiat Oncol Biol Phys, 2014, 88(5): 998-1003.
|
| [20] |
Di Saverio S, Catena F, Santini D, et al. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up [J]. Breast Cancer Res Treat, 2008, 109(3): 405-416.
|
| [21] |
Gilleard O, Goodman A, Cooper M, et al. The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ [J]. World J Surg Oncol, 2008, 18(6): 61.
|
| [22] |
Silverstein MJ, Poller DN, Barth A, et al. Intraductal breast carcinoma: experiences from the Breast Center in Van Nuys, California [J]. Recent Results Cancer Res, 1996, 140: 139-153.
|
| [23] |
Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast [J]. N Engl J Med, 1999, 340(19): 1455-1461.
|
| [24] |
Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group [J]. J Clin Oncol, 2009, 27(32): 5319-5324.
|
| [25] |
McCormick B, Moughan J, Hudis C, et al. Low-risk breast ductal carcinoma in situ (DCIS): results from the radiation therapy oncology group 9804 phase 3 trial [J]. Int J Radiat Oncol Biol Phys, 2012, 84(3): S5.
|
| [26] |
McCormick B, Winter K, Hudis C, et al. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation[J]. J Clin Oncol, 2015, 33(7): 709-715.
|
| [27] |
Solin LJ, Gray R, Baehner FL, et al. A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast [J]. J Natl Cancer Inst, 2013, 105(10): 701-710.
|
| [28] |
Rakovitch E, Nofech-Mozes S, Hanna W, et al. A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone[J]. Breast Cancer Res Treat, 2015, 152(2): 389-398.
|
| [29] |
Sagara Y, Freedman RA, Vaz-Luis I, et al. Patient prognostic score and associations with survival improvement offered by radiotherapy after breast-conserving surgery for ductal carcinoma in situ: a population-based longitudinal cohort study[J]. J Clin Oncol, 2016, 34(11): 1190-1196.
|
| [30] |
Francis A, Thomas J, Fallowfield L, et al. Addressing overtreatment of screen detected DCIS; the LORIS trial[J]. Eur J Cancer, 2015, 51(16): 2296-2303.
|